Early hemoglobin response to epoetin alfa is associated with significantly better clinical outcomes in breast cancer patients

被引：0
|
作者：
Lefevbre, P
Rosberg, J
Duh, MS
McKenzie, RS
Fastenau, J
Piech, CT
机构：
[1] Anal Grp Inc, Boston, MA USA
[2] Ortho Biotech Clin Affairs LLC, Bridgewater, NJ USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2004年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S231 / S231
页数：1
相关论文
共 50 条
  • [31] Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy
    Henry, David H.
    Dahl, Naomi V.
    Auerbach, Michael
    Tchekmedyian, Simon
    Laufman, Leslie R.
    ONCOLOGIST, 2007, 12 (02): : 231 - 242
  • [32] Anemia and epoetin alfa in high-dose chemotherapy programs for breast cancer patients
    Danova, M
    Ferrari, S
    SEMINARS IN ONCOLOGY, 2002, 29 (03) : 21 - 25
  • [33] Hematological and quality of life (QOL) outcomes in anaemic cancer patients treated, with Epoetin alfa
    Glaspy, J
    Demetri, GD
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 336 - 336
  • [34] Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice
    Glaspy, J
    Bukowski, R
    Steinberg, D
    Taylor, C
    Tchekmedyian, S
    VadhanRaj, S
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1218 - 1234
  • [35] Erythropoietic agents in routine clinical practice: a retrospective observational survey of epoetin alfa, epoetin beta and darbepoetin alfa use in anaemia patients with cancer
    Pujade-Lauraine, Eric
    Richard, Alain J.
    Sapede, Claudine
    ANNALS OF ONCOLOGY, 2004, 15 : 220 - 220
  • [36] Rapid hemoglobin response in anemic cancer patients undergoing chemotherapy or chemoradiation therapy receiving once-weekly epoetin alfa treatment
    Shasha, D
    George, M
    BLOOD, 2002, 100 (11) : 17B - 17B
  • [37] HOXB9 IS SIGNIFICANTLY ASSOCIATED WITH POOR CLINICAL OUTCOMES IN ER-POSITIVE BREAST CANCER PATIENTS
    Seki, H.
    Hayashida, T.
    Jinno, H.
    Takahashi, M.
    Shigemichi, H.
    Asanuma, F.
    Yamada, Y.
    Kitagawa, Y.
    BREAST, 2013, 22 : S62 - S62
  • [38] RE: Adding Epoetin Alfa to Intense Dose-Dense Adjuvant Chemotherapy for Breast Cancer: Randomized Clinical Trial Response
    Moebus, Volker
    Jackisch, Christian
    Schneeweiss, Andreas
    Huober, Jens
    Lueck, Hans-Joachim
    Du Bois, Andreas
    Thomssen, Christoph
    Kurbacher, Christian
    Kuhn, Walther
    Nitz, Ulrike A.
    Runnebaum, Ingo B.
    Hinke, Axel
    Kreienberg, Rolf
    Untch, Michael
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (03):
  • [39] Greater area under the hemoglobin change curve is associated with improved outcomes in elderly patients receiving epoetin alfa for chemotherapy-related anemia
    McKenzie, SR
    Duh, MS
    Lefevbre, P
    Fastenau, JM
    Piech, CT
    BLOOD, 2004, 104 (11) : 860A - 860A
  • [40] Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer - Implications for use in gynecologic surgery
    Stovall, TG
    JOURNAL OF REPRODUCTIVE MEDICINE, 2001, 46 (05) : 531 - 538
12345